Invited Speakers Biography

Simon Cherry

Cherry-Simon_001Simon R. Cherry, Ph.D. is Professor in the Departments of Biomedical Engineering and Radiology at the University of California, Davis. His research interests center around biomedical imaging and in particular the development and application of in vivo molecular imaging systems. His early accomplishments were in developing and applying high resolution systems for positron emission tomography (PET), in particular the microPET technology that was subsequently widely adopted in academia and industry. He has contributed to the development of high performance detectors for PET, and to multimodality imaging systems, for example first demonstrations of hybrid PET/MRI systems. He currently co-leads the EXPLORER project which aims to develop the world’s first total-body PET/CT scanner. His laboratory also developed the concept of Cerenkov luminescence imaging as an innovative way to image beta-emitting radionuclides non-invasively using sensitive optical cameras and is currently exploring the use of Cerenkov radiation as an internal light source for phototherapy and for fast timing in PET. The technologies developed by his laboratory have been broadly applied in biomedical science to study diseases processes and measure the effects of therapeutic interventions. Dr. Cherry also serves as Editor-in-Chief of the journal Physics in Medicine and Biology and is lead author of the widely-used textbook Physics in Nuclear Medicine.

 

 


 Joel Karp

karp

PhD, Professor of Radiologic Physics
Department of Radiology and Physics & Astronomy, University of Pennsylvania
Section Chief, Physics & Instrumentation Group, Department of Radiology
Sub-Core Director, PET/SPECT/CT, Small Animal Imaging Facility
Director, Physics, Positron Emission Tomography Facility

 

 

 

 


 Ramsey Badawi

Ramsey_Badawi_255x300

Ramsey Badawi is Professor, Endowed Chair in Molecular Imaging, Chief of Nuclear Medicine and Vice-Chair for Research in the Department of Radiology, and Professor of Biomedical Engineering at UC Davis. He also serves as co-director of the Biomedical Technology Program at the UC Davis Comprehensive Cancer Center. He obtained his PhD in PET Physics at the University of London in 1998, specializing in normalization and data corrections for fully 3D PET. After a postdoctoral fellowship at the University of Washington, Seattle under the mentorship of Dr. Tom Lewellen, he joined the Dana Farber Cancer Institute in 2000, where he helped to set up their first clinical PET service. In 2004 he joined UC Davis. His interests are in the development of high resolution PET/CT scanners for extremity imaging in humans, ultra-high resolution scanners for animal imaging and re-configurable PET systems. He is also interested in applications of advanced reconstruction methods for parametric imaging in humans. With Simon Cherry, he co-leads the EXPLORER project which is developing the world’s first total-body PET/CT scanner.

 

 


David A. Mankoff

mankoff

Dr. David Mankoff is Gerd Muehllehner Professor of Radiology, Vice-Chair for Research in Radiology, and Director of the PET Center at the Perelman School of Medicine at the University of Pennsylvania. Dr. Mankoff is board-certified in Nuclear Medicine and holds a PhD in Bioengineering focusing on PET instrumentation. He practices Nuclear Medicine at the University of Pennsylvania, with a special interest in oncologic applications of molecular imaging and radionuclide treatment of endocrine tumors and other cancers. Dr. Mankoff’s research focuses on molecular imaging of cancer, primarily on breast cancer, and emphasizes therapeutic monitoring, identifying factors mediating therapeutic resistance, and the translation of new methods to clinical trials.   He also focuses on imaging methodology and quantitative imaging methods related to molecular cancer imaging. Dr. Mankoff is a Komen Scholar for the Susan G. Komen Foundation. He also Chairs the Experimental Imaging Sciences Committee and serves as Co-Chair of the Scientific Program Committee of ECOG-ACRIN. Dr. Mankoff is a past member and President of the American Board of Nuclear Medicine. Dr. Mankoff is on the editorial boards of Nuclear Medicine and Biology, Breast Cancer Research, Journal of Nuclear Medicine, The Breast Journal, and Clinical Cancer Research and serves as an Associate Editor for Breast Cancer Research and the Journal of Nuclear Medicine.

 


Terry Jones

Terry informal smaller 3Terry Jones is a medical physicist who has been involved in the development and applications of positron emitting radioisotopes in medicine since 1968. When at the former Medical Research Council’s, Cyclotron Unit, at Hammersmith Hospital, London, he initiated the UK’s first PET program in the late 1970’s. He undertook developments in PET methodology which included collaborations with industrial manufacturers of PET scanners. Together with medical colleagues at the Royal Postgraduate Medical School at Hammersmith Hospital, he fostered the research applications of PET methodology in Neurology, Psychiatry, Oncology, Cardiology and Pulmonary Medicine. He was awarded an MRC travelling fellowship in 1972 to work at the University of Washington St Louis and the MGH in Boston, where he recorded the first image of human brain metabolism by using oxygen-15. To support pre-clinical studies, he established the world’s first dedicated small–animal PET scanner. At the MRC Cyclotron Unit, he rose to the position of acting director and professor of medical physics at Imperial College London. He then went on to co-establish the state-of-the-art PET based Wolfson Molecular Imaging Centre at Manchester University where he was professor of Molecular Imaging. He has co-authored over 300 scientific publications. He is a fellow of the Institute of Physics and Engineering in Medicine and in 1999 was elected as a fellow of the UK’s Academy of Medical Science. He is currently visiting professor at the University of California, Davis and co-director of the PET Research Advisory Company. Currently he is engaged in identifying the clinical research applications of Total Body PET Scanning.

 


Dimitris Visvikis

10/10/13: IPEM, York.Dimitris Visvikis is a director of research with the National Institute of Health and Medical Research (INSERM) in France and the Director of the Medical Image Processing Lab in Brest (LaTIM, UMR1101). He obtained his PhD from the University of London in 1996 working in PET detector development within the Joint Department of Physics in the Royal Marsden Hospital and the Institute of Cancer Research. After working as a Senior Research Fellow in the Wolfson Brain Imaging Centre of the University of Cambridge he joined the Institute of Nuclear Medicine as Principal Medical Physicist in University College London where he introduced and worked for five years with one of the first clinical PET/CT systems in the world. He has spent the majority of his scientific activity in the field of PET imaging, including developments in both hardware and software domains. His current research interests focus on improvement in PET/CT image quantitation for specific oncology applications, such as response to therapy and radiotherapy treatment planning, through the development of methodologies for detection and correction of respiratory motion, 4D PET image reconstruction,  partial volume correction, tumour volume segmentation and tumour activity distribution characterisation algorithms, as well as the development and validation of Monte Carlo simulations for emission tomography and radiotherapy treatment dosimetry applications. He is a member of numerous professional societies such as IPEM (Fellow, Past Vice-President International), IEEE (Senior Member, Past NPSS NMISC chair), AAPM, SNM (CaIC board of directors 2007-2012), EANM. He is also the first Editor in Chief of the IEEE Transactions in Radiation and Plasma Medical Sciences.